About FDA’s Biomarker Qualification Program

Описание к видео About FDA’s Biomarker Qualification Program

Dr. Janet Woodcock, Director of FDA’s Center for Drug Evaluation and Research, delves into how and why CDER’s Biomarker Qualification Program supports the development of biomarkers by different groups and the benefits of the qualification process for regulatory decision-making and public adoption of new biomarkers.
Learn more about FDA’s Biomarker Qualification Program at http://www.fda.gov/Drugs/DevelopmentA...

Комментарии

Информация по комментариям в разработке